Bloxiverz

Product NDC: 51754-1200
Requested package NDC: 51754-1200-3
11-digit product format: 517541200
Labeler code: 51754
Product ID: 51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Neostigmine Methylsulfate
Dosage form: INJECTION
Route: INTRAVENOUS
Labeler: Exela Pharma Sciences, LLC
Application: NDA204078
Marketing category: NDA
Marketing start: 2023-11-06
Substance: NEOSTIGMINE METHYLSULFATE
Active strength: 1 mg/mL
Pharmacologic classes: Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N204078-001	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-05-31
N204078-002	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-05-31
N204078-003	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2023-10-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 100 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS		RLD	2013-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2013-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-002	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204078-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-002	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-002	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-002	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-002	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-002	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-002	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-002	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N204078-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-002	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-002	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-002	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-001	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-002	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N204078-001	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N204078-002	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N204078-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N204078-002	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N204078-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N204078-002	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N204078-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N204078-002	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N204078-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N204078-002	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N204078-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N204078-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N204078-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N204078-002	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N204078-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N204078-002	AP	1	`87673890dc5c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Bloxiverz
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NEOSTIGMINE METHYLSULFATE	1 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
98IMH7M386	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
311935	Internal RxNorm lookup
311936	Internal RxNorm lookup
1429282	Internal RxNorm lookup
1429284	Internal RxNorm lookup
1668225	Internal RxNorm lookup
2673236	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
d2f55643-2b0d-4ef9-a9d8-b7138b314372	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b	Product name	1	20231002
6c2b16d0-96e9-444e-98c5-9883cd6eb72d	Product name	2	20230316
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
ad279e69-d021-f6bd-1150-2b55f23832d5	Product name	9	20211014
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51754-1200-3	Bloxiverz	10 in 1 CARTON	INJECTION	10		18
51754-1200-3	Bloxiverz	5 mL in 1 SYRINGE, PLASTIC	INJECTION	5		18

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51754-1200-3	ML - Milliliter	51754-1200	96535e8b-91f8-490c-97e1-57bf509286ae	1	2024-11-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51754-1200	BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [EXELA PHARMA SCIENCES, LLC]	18	Current NDC, 2 package rows	20240117_d2f55643-2b0d-4ef9-a9d8-b7138b314372.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bloxiverz	NEOSTIGMINE METHYLSULFATE	Exela Pharma Sciences, LLC	d2f55643-2b0d-4ef9-a9d8-b7138b314372	2023-12-31	Warnings, Adverse reactions	Exact identifier application applno (NDA): 204078 application number: NDA204078 ndc (package): 51754-1200-3 ndc (product): 51754-1200 ndc11 (package): 51754120003

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98IMH7M386	NEOSTIGMINE METHYLSULFATE	51-60-5	NEOSTIGMINE METHYLSULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1429282	Bloxiverz 0.5 MG/ML Injectable Solution	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1429284	Bloxiverz 1 MG/ML Injectable Solution	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
2673236	Bloxiverz 5 MG in 5 ML Prefilled Syringe	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311935	neostigmine methylsulfate 0.5 MG/ML Injectable Solution	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1668225	neostigmine methylsulfate 5 MG in 5 ML Prefilled Syringe	PSN	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
2673236	5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe [Bloxiverz]	SBD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1429282	neostigmine methylsulfate 0.5 MG/ML Injectable Solution [Bloxiverz]	SBD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1429284	neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz]	SBD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1668225	5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe	SCD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311935	neostigmine methylsulfate 0.5 MG/ML Injectable Solution	SCD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SCD	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
2673236	5 ML Bloxiverz 1 MG/ML Prefilled Syringe	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1429282	Bloxiverz 0.5 MG/ML Injectable Solution	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1429284	Bloxiverz 1 MG/ML Injectable Solution	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
2673236	Bloxiverz 5 MG per 5 ML Prefilled Syringe	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311935	neostigmine methylsulfate 0.5 MG/ML Injectable Solution	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18
1668225	neostigmine methylsulfate 5 MG per 5 ML Prefilled Syringe	SY	d2f55643-2b0d-4ef9-a9d8-b7138b314372	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
51754-1200-3	51754120003	10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1 SYRINGE, PLASTIC	2023-12-31	No	No	Current